GL1X · GenesisL1 explorer

Ligand · Q9S

Q9S · 5-{4-[(5-amino-1,3,4-thiadiazol-2-yl)oxy]piperidin-1-yl}-1,3,4-thiadiazol-2-amine

Q9S, 5-{4-[(5-amino-1,3,4-thiadiazol-2-yl)oxy]piperidin-1-yl}-1,3,4-thiadiazol-2-amine (C9 H13 N7 O S2, 299.4 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5…

Component
Q9S
Formula
C9 H13 N7 O S2
Class
ligand
Structures
2
PDB entries
1

Binding sites

Q9S in 2 structures; the first of them:

  • 6UK6 · Crystal structure of human GAC in complex with inhibitor UPGL00018 · Q9S A601 · binds LYS320, LEU321, PHE322, LEU323, ASN324, TYR394, LYS320, LEU321 and 4 more
  • 6UK6 · Crystal structure of human gac in complex with inhibitor UPGL00018 · Q9S A601 · binds LYS320, LEU321, PHE322, LEU323, ASN324, TYR394, LYS320, LEU321 and 3 more

Residues it binds most

LEU 4, LYS 4, PHE 4, TYR 4, ASN 4 (residue and the binding sites it lines).

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.